vs
QuidelOrtho Corp（QDEL）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Rithm Capital Corp.的季度营收约是QuidelOrtho Corp的1.2倍（$828.2M vs $699.9M），Rithm Capital Corp.净利率更高（13.2% vs -104.7%，领先117.9%），Rithm Capital Corp.同比增速更快（508.5% vs -3.7%），过去两年QuidelOrtho Corp的营收复合增速更高（-2.9% vs -17.9%）
奎德尔奥索公司是美国的诊断医疗产品制造商，旗下产品面向全球市场销售，深耕体外诊断领域，为医疗机构及相关用户提供专业的检测解决方案，助力全球医疗健康服务效率提升。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
QDEL vs RITM — 直观对比
营收规模更大
RITM
是对方的1.2倍
$699.9M
营收增速更快
RITM
高出512.2%
-3.7%
净利率更高
RITM
高出117.9%
-104.7%
两年增速更快
QDEL
近两年复合增速
-17.9%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $699.9M | $828.2M |
| 净利润 | $-733.0M | $109.5M |
| 毛利率 | — | — |
| 营业利润率 | -100.7% | 29.9% |
| 净利率 | -104.7% | 13.2% |
| 营收同比 | -3.7% | 508.5% |
| 净利润同比 | -3583.4% | 27.7% |
| 每股收益（稀释后） | $-10.78 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QDELRITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $699.9M | $1.1B | ||
| Q2 25 | $613.9M | $1.2B | ||
| Q1 25 | $692.8M | $768.4M | ||
| Q4 24 | $707.8M | $2.1B | ||
| Q3 24 | $727.1M | $619.5M | ||
| Q2 24 | $637.0M | $1.2B |
净利润QDELRITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | — | $85.0M | ||
| Q3 25 | $-733.0M | $221.5M | ||
| Q2 25 | $-255.4M | $311.7M | ||
| Q1 25 | $-12.7M | $78.8M | ||
| Q4 24 | $-178.4M | $290.2M | ||
| Q3 24 | $-19.9M | $121.7M | ||
| Q2 24 | $-147.7M | $235.6M |
营业利润率QDELRITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | — | 13.8% | ||
| Q3 25 | -100.7% | 21.4% | ||
| Q2 25 | -29.4% | 25.2% | ||
| Q1 25 | 4.7% | 7.4% | ||
| Q4 24 | -14.2% | 23.8% | ||
| Q3 24 | 2.1% | 7.3% | ||
| Q2 24 | -18.4% | 23.6% |
净利率QDELRITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | -104.7% | 20.0% | ||
| Q2 25 | -41.6% | 25.6% | ||
| Q1 25 | -1.8% | 10.3% | ||
| Q4 24 | -25.2% | 14.0% | ||
| Q3 24 | -2.7% | 19.7% | ||
| Q2 24 | -23.2% | 19.2% |
每股收益（稀释后）QDELRITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | — | $0.09 | ||
| Q3 25 | $-10.78 | $0.35 | ||
| Q2 25 | $-3.77 | $0.53 | ||
| Q1 25 | $-0.19 | $0.07 | ||
| Q4 24 | $-2.54 | $0.50 | ||
| Q3 24 | $-0.30 | $0.20 | ||
| Q2 24 | $-2.20 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.1M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $9.1B |
| 总资产 | $5.7B | $53.4B |
| 负债/权益比越低杠杆越低 | 1.23× | — |
8季度趋势，按日历期对齐
现金及短期投资QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | $98.1M | $1.6B | ||
| Q2 25 | $151.7M | $1.6B | ||
| Q1 25 | $127.1M | $1.5B | ||
| Q4 24 | $98.3M | $1.5B | ||
| Q3 24 | $143.7M | $1.6B | ||
| Q2 24 | $107.0M | $1.2B |
总债务QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | $35.4B | ||
| Q3 25 | $2.5B | $32.2B | ||
| Q2 25 | $2.1B | $31.2B | ||
| Q1 25 | $2.1B | $32.2B | ||
| Q4 24 | $2.1B | $32.6B | ||
| Q3 24 | $2.2B | $29.6B | ||
| Q2 24 | $2.2B | $30.1B |
股东权益QDELRITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | — | $8.4B | ||
| Q3 25 | $2.0B | $8.5B | ||
| Q2 25 | $2.8B | $7.9B | ||
| Q1 25 | $3.0B | $7.8B | ||
| Q4 24 | $3.0B | $7.8B | ||
| Q3 24 | $3.2B | $7.7B | ||
| Q2 24 | $3.2B | $7.3B |
总资产QDELRITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | — | $53.1B | ||
| Q3 25 | $5.7B | $47.2B | ||
| Q2 25 | $6.4B | $44.3B | ||
| Q1 25 | $6.5B | $45.3B | ||
| Q4 24 | $6.4B | $46.0B | ||
| Q3 24 | $6.8B | $42.3B | ||
| Q2 24 | $6.7B | $42.0B |
负债/权益比QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | 4.20× | ||
| Q3 25 | 1.23× | 3.79× | ||
| Q2 25 | 0.74× | 3.92× | ||
| Q1 25 | 0.70× | 4.14× | ||
| Q4 24 | 0.72× | 4.18× | ||
| Q3 24 | 0.68× | 3.87× | ||
| Q2 24 | 0.70× | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-94.7M | — |
| 自由现金流率自由现金流/营收 | -13.5% | — |
| 资本支出强度资本支出/营收 | 7.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-153.1M | — |
8季度趋势，按日历期对齐
经营现金流QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | $-114.6M | ||
| Q3 25 | $-45.5M | $-2.0B | ||
| Q2 25 | $-46.8M | $-557.1M | ||
| Q1 25 | $65.6M | $1.4B | ||
| Q4 24 | $63.7M | $-1.8B | ||
| Q3 24 | $117.9M | $768.1M | ||
| Q2 24 | $-97.9M | $-55.7M |
自由现金流QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-94.7M | — | ||
| Q2 25 | $-84.3M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $16.5M | — | ||
| Q3 24 | $71.4M | — | ||
| Q2 24 | $-133.2M | — |
自由现金流率QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -13.5% | — | ||
| Q2 25 | -13.7% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 9.8% | — | ||
| Q2 24 | -20.9% | — |
资本支出强度QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 5.5% | — |
现金转化率QDELRITM
| Q1 26 | — | — | ||
| Q4 25 | — | -1.35× | ||
| Q3 25 | — | -9.22× | ||
| Q2 25 | — | -1.79× | ||
| Q1 25 | — | 18.03× | ||
| Q4 24 | — | -6.04× | ||
| Q3 24 | — | 6.31× | ||
| Q2 24 | — | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
